Showing results (1-10 of 332) with videos related to

Sort By:
Pageof 34
World Journal of Gastroenterology|December 29, 2021
Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft <i>vs</i> host diseaseQuentin Le Bastard, Patrice Chevallier, Emmanuel Montassier
Leukemia & Lymphoma|October 20, 2020
FLT3 ligand in acute myeloid leukemia: a simple test with deep implicationsPierre Peterlin, Patrice Chevallier, Steven Knapper, et al.
Cancers|August 7, 2021
Relevance of Polymorphic KIR and HLA Class I Genes in NK-Cell-Based Immunotherapies for Adult Leukemic PatientsLéa Dubreuil, Patrice Chevallier, Christelle Retière, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 27, 2025
Elderly Acute Lymphoblastic Leukemia: Low-Dose Chemotherapy and Immunotherapy CombinationsPerrine Moyer, Aude-Marie Fourmont, Lucie Freiman, et al.
Leukemia Research|November 22, 2007
Re-administration of a combination of chemotherapy + Gemtuzumab at relapse in CD33+ AML patient allows to second remission and is feasible without extra toxicityPatrice Chevallier, Cyril Touzeau, Sameh Ayari, et al.
International Journal of Hematology|August 1, 2008
Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expressionPatrice Chevallier, Beatrice Mahe, Richard Garand, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 5, 2025
Inotuzumab Ozogamicin as First-Line Therapy in Acute Lymphoblastic LeukemiaElias J Jabbour, Philippe Rousselot, Nicola Gokbuget, et al.
Leukemia Research|November 8, 2008
A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: the AFR-15 trialPatrice Chevallier, Mathilde Hunault-Berger, Fabrice Larosa, et al.
Haematologica|November 9, 2004
Overexpression of Her2/neu is observed in one third of adult acute lymphoblastic leukemia patients and is associated with chemoresistance in these patientsPatrice Chevallier, Nelly Robillard, Soraya Wuilleme-Toumi, et al.
Biomedicines|February 25, 2023
Two Ways of Targeting a CD19 Positive Relapse of Acute Lymphoblastic Leukaemia after Anti-CD19 CAR-T CellsAudrey Grain, Jocelyn Ollier, Thierry Guillaume, et al.
Pageof 34